Company intelligence / Profile preview

WiCON International Group

Bellevue, Washington, United States

Ownership: Private
Employees: ~9
Development stage: Other

Overview

WiCON International Group is a leading provider of business intelligence, strategic consulting, and publishing services focused on the Chinese pharmaceutical and biopharmaceutical sectors. Its flagship product is "Pharma China," an English-language media platform offering news, analysis, databases, and market insights for international companies operating or investing in China's healthcare market. The company has been active since 1991 and serves multinational pharma companies, CROs, investment banks, consulting firms, and industry associations.

Industry: Consulting

Beyond the preview

Go deeper on WiCON International Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WiCON International Group.

Explore the full profile